Too long to read? Go for the highlights below. Refugee-led initiatives in Uganda and Kenya are training thousands in low-cost mushroom cultivation, creating revenue streams through products ranging from oyster mushroom coffee to medicinal skincare African mushroom entrepreneurs challenge persistent misconceptions that fungi cannot be cultivated, demonstrating that mushroom farming offers faster income generation and better climate resilience than traditional crops With 1.5 bi

This is the fourth article in a six-part series exploring critical themes shaping the future of functional mushrooms, in partnership with Finnish biotech company KÄÄPÄ Biotech . For centuries, chaga has been one of nature’s most powerful secrets. In the Nordics, in the cold, on slow-growing birch forests, this charcoal-black conk develops over many years. Throughout that time it accumulates the bioactive compounds that have made it an essential part of traditional medicine ac

China's National Health Commission has granted the country's first regulatory approval for mycoprotein, establishing detailed national specifications that provide clarity for future applications

A mushroom sold in Asian markets causes remarkably consistent hallucinations of miniature people in 96% of affected individuals, a phenomenon documented independently across China, Papua New Guinea, and the Philippines

MIT chemists have synthesized verticillin A for the first time since its discovery in 1970, overcoming molecular complexity that stymied researchers for decades

Ethanol made from shiitake-treated wood performs well, showing the potential for pairing mushroom farming with renewable fuel production.

Psilocybin Depression Treatment Shows Shared Brain Mechanisms with Standard Antidepressants

Ethanol made from shiitake-treated wood performs well, showing the potential for pairing mushroom farming with renewable fuel production.

Ethanol made from shiitake-treated wood performs well, showing the potential for pairing mushroom farming with renewable fuel production.

Reported Candidozyma auris cases in Europe rose to 1,346 in 2023 across 18 countries, with several reporting regional or national spread. The fungus is highly transmissible, difficult to control, and often resistant to antifungal drugs, posing a significant challenge for hospitals. Europe’s limited surveillance and laboratory capacity leave the true scale of infections uncertain.